Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies-Reference-Cited by-同舟云学术

Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies

Published:2016-01 Issue:1 Volume:38 Page:37-43
ISSN:1516-8484
Container-title:Revista Brasileira de Hematologia e Hemoterapia
language:en
Short-container-title:Revista Brasileira de Hematologia e Hemoterapia

Author:

Tietsche de Moraes Hungria Vania,Allen Syreeta,Kampanis Petros,Soares Elyara Maria

Publisher

Elsevier BV

Subject

Hematology

Reference47 articles.

1. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment;Gertz;Am J Hematol,2014

2. Review of 1027 patients with newly diagnosed multiple myeloma;Kyle;Mayo Clin Proc,2003

3. Clinical Pathology Rounds: the case of the anaplastic carcinoma that was not – potential problems in the interpretation of monoclonal proteins;Bridgen;Lab Med,2000

4. Renal insufficiency due to light chain multiple myeloma;van Zaanen;Ned Tijdschr Geneeskd,2000

5. Difficulties identifying a monoclonal component in a Bence-Jones multiple myeloma, a clinical case;Chaves Lameiro;Biochim Clin,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential role of serum polyclonal free light chains as markers of immune activation in psoriatic patients;European Journal of Dermatology;2023-02

2. The organization of the protein unit: a beneficial example founded on evidence based laboratory medicine criteria and on the appropriate use of the available resources;BIOCHIM CLIN;2019

3. The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases;Biomedicine & Pharmacotherapy;2017-07

4. Detection of the value of consecutive serum total light chain (sTLC) in patients diagnosed with diffuse large B cell lymphoma;Annals of Hematology;2016-09-14